RecruitingNCT04806295

The Leukemia and Lymphoma Society (LLS) National Research Registry


Sponsor

Blood Cancer United

Enrollment

1,000 participants

Start Date

Jul 24, 2017

Study Type

OBSERVATIONAL

Conditions

Summary

The Leukemia and Lymphoma Society (LLS) has built a National Research Registry to evaluate real world experiences and medical outcomes for people with blood cancer, before, during, and after blood cancer treatments.


Eligibility

Min Age: 21 Years

Plain Language Summary

Simplified for easier understanding

This is a national research registry run by the Leukemia and Lymphoma Society that collects health data from blood cancer patients before, during, and after treatment. The goal is to build a large database to advance research into better treatments for blood cancers. **You may be eligible if...** - You have been diagnosed with any type of blood cancer (such as leukemia, lymphoma, or myeloma) - You are at any stage of your treatment journey — before, during, or after treatment - You are willing to share your health information and sign a consent form **You may NOT be eligible if...** - You are unwilling or unable to sign an informed consent form - You do not have a blood cancer diagnosis Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERany/all treatments for blood cancer

Following people undergoing any/all treatments for blood cancer.


Locations(1)

Lymphoma and Leukemia Society

Rye Brook, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04806295


Related Trials